Amgen's EPS increase 5% YoY to $3.43 in Q3

Wednesday, 28. October 2020 21:04

Amgen Inc. reported on Wednesday that its GAAP earnings per share (EPS) for the third quarter of fiscal 2020 stood at $3.43, up 5% from the same period a year ago.

The biopharmaceutical firm also revealed that its total revenues in the third quarter were $6.4 billion, a 12% gain year-on-year, while its net income amounted to $2 billion, representing a 3% rise compared to the same quarter of 2019. Meanwhile, the operating income for the third trimester declined by 1% year on year to land at $2.45 billion.

"Amgen continues to deliver strong, volume-driven growth in a challenging environment, while also advancing new medicines in our pipeline," Chairman and CEO Robert Bradway commented in the press release.

The company's shares fell by 0.54% in after-hours trading following the release of the report.

Related Links: Amgen Inc.
Breaking the News / MS